SVRA:NASDAQ, Savara Inc.

SVRA stock overview

Savara Inc. (SVRA:NASDAQ) closed at $4.47 on November 16, 2026, down 3.77% on the day. The stock trades 36.3% below its 52-week high of $7.01 and 8.1% above its 52-week low of $4.13. Over the past year, it gained 6.3%. Savara Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$4.47
Day change
-3.77%
Volume
2,769,865
Average volume
2,288,426
Market cap
985M+
52-week range
$4.13 – $7.01
50-day average
$4.93
200-day average
$5.33

Price action over the past year

In 252 trading sessions since November 14, 2025, SVRA closed higher on 111 days (44%). Its best day was November 28, 2025 (+17.35%) and its worst was August 13, 2026 (-7.54%). The stock moved 10% or more in a single session 3 times.

Recent signals

SVRA news

About Savara Inc.

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. Its lead product candidate is AIR001, a sodium nitrite solution for inhalation through nebulization, which is in Phase II clinical stage for the treatment of heart failure with preserved ejection fraction, as well as in Phase I/II study in patients with cystic fibrosis. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Similar stocks

Find more stocks like SVRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.